Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Cogna Pharma AB
AB
Active
Org 5594919861
Hättkvarnsgatan 1
Temporary employment agency activities and other human resource provisions · NACE 7820
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 311K
EBITDA margin
85.4%
Equity ratio
68.7%
Financial strength
Net profit 2024
SEK 211K
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 311K
—
EBITDA
SEK 266K
—
Net profit
SEK 211K
—
Total assets
SEK 343K
—
Equity
SEK 236K
—
Employees
0
—
Company information
Legal name
Cogna Pharma AB
Org number
5594919861
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
6 augusti 2024
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Produktutveckling och försäljning av kosttillskott. Konsulttjänster inom detaljhandeln för apotek samt därmed förenlig verksamhet.
Contact
Address
Hättkvarnsgatan 1
Email
michael.bitar01@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Temporary employment agency activities and other human resource provisions
Companies in Järfälla
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
311
Staff expenses
—
EBITDA
266
Depreciation & amort.
—
EBIT
266
Net financials
—
Profit before tax
266
Tax
−55
Net profit
211
Balance sheet
SEK thousands
Item
2024
Total assets
343
Equity
236
Long-term debt
—
Short-term debt
107
Total debt
107
Financial ratios
5-year trend
EBITDA margin
85.4%
This company
15.8%
Market median
+441% vs market
2024
2024
Equity ratio
68.7%
This company
38.2%
Market median
+80% vs market
2024
2024
Return on equity
89.4%
This company
18.4%
Market median
+386% vs market
2024
2024
Net profit margin
67.8%
This company
8.1%
Market median
+737% vs market
2024
2024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
2024
2024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-08-06 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MB
Michael Bitar
Board of Directors
2024
JS
Johan Sathishkumar Forsberg
Deputy Board Member
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Cogna Pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Michael Bitar
Board of Directors
0 companies
Johan Sathishkumar Forsberg
Deputy Board Member
0 companies